✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic International PolicyMarket AccessHealthcare IntegrationPharmaceutical StandardsRegulatory Framework Why This MattersMarket development in smaller healthcare systems...
Medipharm Labs sees 43% growth in international medical cannabis revenue in 2025
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Market AccessProduct QualityInternational PolicyPharmaceutical Standards Why This MattersInternational revenue growth for pharmaceutical-grade cannabis...
Japan Cracks Down on CBN: The End of a Cannabis ‘Gray Area’ | High Times
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbnRegulationSleepInternational PolicyMinor Cannabinoids Why This MattersJapan's regulatory classification of CBN as a controlled substance...
Meet Bloomwell, The Telehealth Company Growing Germany’s $900 Million Cannabis Industry
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic TelemedicineInternational PolicyHealthcare DeliveryClinical StandardsMarket Access Why This Matters Germany’s telehealth cannabis market represents a...